Liontrust Investment Partners LLP reduced its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 6.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,421 shares of the semiconductor company's stock after selling 2,043 shares during the period. Liontrust Investment Partners LLP's holdings in Synopsys were worth $13,475,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Cornerstone Planning Group LLC lifted its stake in Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 44 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. bought a new stake in shares of Synopsys during the 4th quarter worth $29,000. Cloud Capital Management LLC bought a new stake in shares of Synopsys during the 1st quarter worth $36,000. Finally, Meeder Asset Management Inc. raised its stake in shares of Synopsys by 33.3% during the 1st quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock worth $45,000 after purchasing an additional 26 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Insider Activity
In other news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the transaction, the chief executive officer directly owned 71,589 shares of the company's stock, valued at $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive directly owned 1,485 shares in the company, valued at approximately $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 27,686 shares of company stock valued at $13,001,048 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Trading Up 0.3%
Shares of SNPS traded up $1.55 during mid-day trading on Friday, hitting $617.91. 881,572 shares of the company's stock traded hands, compared to its average volume of 1,514,814. The firm has a market capitalization of $95.87 billion, a P/E ratio of 44.61, a PEG ratio of 4.09 and a beta of 1.15. The business's 50-day moving average price is $558.90 and its 200-day moving average price is $497.65. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.60 billion. During the same period in the prior year, the firm earned $3.00 earnings per share. The firm's revenue for the quarter was up 10.3% on a year-over-year basis. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analysts Set New Price Targets
SNPS has been the topic of a number of recent analyst reports. The Goldman Sachs Group assumed coverage on Synopsys in a research note on Thursday, July 10th. They set a "buy" rating and a $620.00 target price on the stock. Morgan Stanley reaffirmed an "overweight" rating and set a $715.00 target price (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Rosenblatt Securities lifted their target price on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a report on Friday, July 25th. Stifel Nicolaus set a $550.00 price target on Synopsys in a research report on Monday, April 28th. Finally, Piper Sandler lifted their price target on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a research report on Monday, July 21st. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $630.67.
Check Out Our Latest Stock Analysis on SNPS
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.